HITAP International Unit led by Dr. Yot Teerawattananon has an opportunity to meet Dr. Seth Franklin Berkley, Chief Executive Officer of the GAVI Alliance on his visit to Thailand. Dr. Yot and Dr. Seth meeting and discuss HITAP and iDSI work including GEAR, the Guide to Health Economic Analysis and

On 17th September 2018, Sarah Garner, coordinator of the Innovation, Access and Use team under the Essential Medicines and Health Products program, World Health Organization, had an informal meeting at the Health Intervention and Technology Assessment Program (HITAP). She was eager to learn about HI

The COVID-19 pandemic has taken a toll on the lives and livelihoods of people since 2020 and it has disrupted provision of health services, including for primary health care which is the first point of contact for patients and the first line of defense for the health system.Learn how primary healthc

Health service research (HSR) has changed the way healthcare is delivered to patients and its and quality. The research has continually generated results that, if translated into policy and clinical practices, can improve health outcomes, and provide better patient care and treatment. However, the t

Indoor air pollution has become a significant concern, contributing to the decline in air quality through the presence of gaseous pollutants and particulate matter, especially under poor ventilation. Hospitals, functioning as non-industrial microenvironments, particularly in Thailand, face challenge

Indoor air pollution has become a significant concern, contributing to the decline in air quality through the presence of gaseous pollutants and particulate matter, especially under poor ventilation. Hospitals, functioning as non-industrial microenvironments, particularly in Thailand, face challenges due to insufficient and incomplete databases for

The development of artificial intelligence (AI) in healthcare is advancing rapidly and playing an important role in healthcare worldwide. However, real-world implementation remains challenging in terms of economic value, patient data security, and acceptance by health professionals. Hence, this study was conducted with three main components: (1) a

Gao Qi is a research assistant at Saw Swee Hock School of Public Health, National University of Singapore in collaboration with MIDAS. Research fields include framework construction of health innovation process, early health technology assessment, and traditional health technology assessment. Interested in health policy effects and health innovatio

Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in

Economic evaluation can be a tool to assist policy makers in resource allocation decision making. In cost-utility analysis, health outcomes resulting from health interventions are measured using several methods, for example, Quality-Adjusted Life Year (QALY). The QALY is a single index score in which both health-related quality of life and life exp